Phoenix SENOLYTIX
Houston, US · 1 known investors
Find your way into Phoenix SENOLYTIX
116 people in our graph share verified history with the Phoenix SENOLYTIX team — schools, employers, funds. One of them is your warm intro.
Scott Billerunlockedknows Kevin M. Slawin · together at Columbia University (overlapped)
knows the team · via Bellicum Pharmaceuticals, Inc.
×2knows the team · via Columbia University
×5knows the team · via Baylor College of Medicine
×2knows the team · via Columbia University Vagelos College of Physicians and Surgeons
knows the team · via Memorial Hermann Healthcare System
Phoenix SENOLYTIX develops gene therapies targeting senescent cells to address aging-related conditions. The company utilizes its ApoptiCIDe-CE™ platform technology, validated in human patients, to eliminate unwanted cells in the body.
Founders & leadership
KS
Kevin Slawin, M.D.in𝕏Founder and CEOKevin Slawin is a physician and biotech entrepreneur who co-founded Bellicum Pharmaceuticals and led it to a $161 million IPO in 2014. He is founder and CEO of Phoenix SENOLYTIX, which develops gene therapies targeting senescent cells to address aging-related diseases.
Investors · 1
Frequently asked questions
- What does Phoenix SENOLYTIX do?
- Phoenix SENOLYTIX develops gene therapies targeting senescent cells to address aging-related conditions. The company utilizes its ApoptiCIDe-CE™ platform technology, validated in human patients, to eliminate unwanted cells in the body.
- Who founded Phoenix SENOLYTIX?
- Phoenix SENOLYTIX was founded by Kevin Slawin, M.D..
- Who are Phoenix SENOLYTIX's investors?
- Phoenix SENOLYTIX's investors include Rapha Capital Management, LLC.
- Where is Phoenix SENOLYTIX headquartered?
- Phoenix SENOLYTIX is headquartered in Houston, US.